NCT03627650

Brief Summary

fat grafting in human skin-grafted immature burn scars histological, clinical and photographic follow-up

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2016

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

October 6, 2017

Completed
10 months until next milestone

First Posted

Study publicly available on registry

August 13, 2018

Completed
Last Updated

August 21, 2018

Status Verified

August 1, 2018

Enrollment Period

3.4 years

First QC Date

October 6, 2017

Last Update Submit

August 18, 2018

Conditions

Keywords

burnscarfatgrafting

Outcome Measures

Primary Outcomes (6)

  • Improvement of scar quality by histological assessment

    histology of scar tissue, scoring by 2 independent blinded anatomopathologists, (numerical scoring of fibroblast activity, collagen and elastin organisation, vascularity) scoring range min 1(close to normal tissue) - 3 (scar characteristics)

    6 months

  • improvement of scar quality by physiological testing with cutometer

    measures elasticity of the scar; micrometer; higher values better outcome

    6 months, 1 year

  • Improvement of scar quality by subjective evaluation with numerical Vancouver Scar Scale

    numerical score 0 to 13; ranges vascularity, height/thickness, pliability, and pigmentation

    1 year

  • Improvement of scar quality by subjective evaluation with numerical POSAS (Patient and Observer Scar Assessment Scale) Scale

    numerical score 5 to 50: VSS plus surface area; patient assessments of pain, itching, color, stiffness, thickness, relief

    1 year

  • improvement of scar quality by physiological testing with TEWA-meter (Trans Epidermal Water Loss-meter)

    measures transepidermal water loss; g/m2/h; higher values worse outcome

    6 months, 1 year

  • physiological testing of scar tissue by corneometer

    measures hydration of the epidermis; corneometer units, higher values better outcome

    6 months, 1 year

Study Arms (2)

1 group of 15 patients

EXPERIMENTAL

procedure/surgery: fat grafting injection of scar

Procedure: lipofilling/ fat grafting

Same group of 15 patients

EXPERIMENTAL

procedure/surgery: placebo injection of scar

Procedure: placebo injection

Interventions

liposuction, processing/ cleaning of fat tissue; reinjection with sharp needle transcutaneous

1 group of 15 patients
Same group of 15 patients

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • early skin-grafted deep burn scars
  • otherwise healthy

You may not qualify if:

  • concomitant disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

BurnsCicatrixPlatelet Glycoprotein IV Deficiency

Condition Hierarchy (Ancestors)

Wounds and InjuriesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Maarten AJ Doornaert, MD

    UGent University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
2 skin zones per participant, A and B, 1 is treated, 1 is placebo coin toss determines which zone will be treated, this information is kept in sealed envelope
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomised controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor, Head of Plastic Surgery, Principal Investigator

Study Record Dates

First Submitted

October 6, 2017

First Posted

August 13, 2018

Study Start

May 1, 2013

Primary Completion

September 10, 2016

Study Completion

October 1, 2016

Last Updated

August 21, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share